Wang X, Fan M J, Yu Y F, Fan X Y, Chen J, Lai Y F, Liu Y, Ye H Y, Zhang Z Y, Zhao Y, Wang Y F, Xiang L H, He M, Ma Y
Department of Dermatology, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, People's Republic of China.
Department of Endocrine, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, People's Republic of China.
J Endocrinol Invest. 2024 Jun;47(6):1467-1476. doi: 10.1007/s40618-023-02254-6. Epub 2023 Dec 19.
Acne vulgaris is a prevalent skin condition. We have found that some acromegaly patients have acne. However, no study has examined the relationship between acromegaly and acne.
To explore prevalence and correlation of adult acne in patients with acromegaly.
For this cross-sectional study, we collected questionnaires, clinical information, and laboratory test results of acromegaly patients from January 2022 to December 2022 at Huashan Hospital. Of the 133 questionnaires returned, 123 had valid responses.
Of the 123 patients with acromegaly enrolled in this study, 54.5% had adult acne. No statistically significant difference was found in prevalence between male and female patients. 61.2% of adult acne patients reported late-onset acne. Late-onset acne patients first developed acne years before acromegaly diagnosis (mean of 5.6 years for male and 4.5 years for female patients). Some acne patients have received traditional anti-acne treatment. Moreover, 31% of the patients reported no improvement, and only 3.5% of patients claimed complete resolution of acne after treatment. Before acromegaly treatment, the prevalence of adult acne was 51.2%, with mild acne accounting for 73.0%, moderate acne accounting for 23.8%, and severe acne accounting for 3.2%. After acromegaly treatment, the prevalence of adult acne was significantly decreased to 37.4% (P = 0.007). An overall decrease in acne severity was noted, with 93.5%, 6.5%, and 0% having mild, moderate, and severe acne, respectively. A total of 83.6% of the patients had self-assessed acne remission, and 33.3% of the patients reported complete acne resolution. However, 9.0% of patients reported that their condition had worsened after acromegaly treatment. After treatment, GH, IGF-1, IGF-1 index, insulin levels, and HOMA-IR decreased significantly in all patients with acromegaly (P < 0.05). Acne remission correlated positively with IGF-1 levels, but not with GH levels. The relationship between acromegaly and acne remains to be elucidated.
Our findings provide preliminary evidence of the high prevalence of adult acne in acromegaly patients, and a high rate of late-onset acne as well. Traditional anti-acne treatments are less effective. Acne could be considerably relieved by treating acromegaly. Acne remission positively correlated with IGF-1 decline as well, which revealed the correlation between acne and IGF-1.
寻常痤疮是一种常见的皮肤疾病。我们发现一些肢端肥大症患者患有痤疮。然而,尚无研究探讨肢端肥大症与痤疮之间的关系。
探讨肢端肥大症患者中成人痤疮的患病率及相关性。
在这项横断面研究中,我们收集了2022年1月至2022年12月在华山医院就诊的肢端肥大症患者的问卷、临床信息和实验室检查结果。在回收的133份问卷中,123份有有效回复。
本研究纳入的123例肢端肥大症患者中,54.5%患有成人痤疮。男性和女性患者的患病率无统计学显著差异。61.2%的成人痤疮患者报告为迟发性痤疮。迟发性痤疮患者在肢端肥大症诊断前数年首次出现痤疮(男性平均为5.6年,女性患者平均为4.5年)。一些痤疮患者接受过传统抗痤疮治疗。此外,31%的患者报告治疗后无改善,只有3.5%的患者声称治疗后痤疮完全消退。在肢端肥大症治疗前,成人痤疮的患病率为51.2%,轻度痤疮占73.0%,中度痤疮占23.8%,重度痤疮占3.2%。肢端肥大症治疗后,成人痤疮的患病率显著降至37.4%(P = 0.007)。痤疮严重程度总体下降,轻度、中度和重度痤疮患者分别占93.5%、6.5%和0%。共有83.6%的患者自我评估痤疮缓解,33.3%的患者报告痤疮完全消退。然而,9.0%的患者报告肢端肥大症治疗后病情恶化。治疗后,所有肢端肥大症患者的生长激素(GH)、胰岛素样生长因子-1(IGF-1)、IGF-1指数、胰岛素水平和稳态模型胰岛素抵抗指数(HOMA-IR)均显著下降(P < 0.05)。痤疮缓解与IGF-1水平呈正相关,但与GH水平无关。肢端肥大症与痤疮之间的关系仍有待阐明。
我们的研究结果提供了初步证据,表明肢端肥大症患者中成人痤疮的患病率很高,迟发性痤疮的发生率也很高。传统抗痤疮治疗效果较差。治疗肢端肥大症可使痤疮得到显著缓解。痤疮缓解也与IGF-1下降呈正相关,这揭示了痤疮与IGF-1之间的相关性。